NIHR Maudsley BRC Blog

Our latest news and events

Global ALS/MND recognition Day

Today, Monday 21st of June, marks the Global Day of Recognition for AMD/MND. To mark this, we discuss MND research happening at the King's CRF with Lead Research Nurse Theresa and a participant on one of the trials.

By NIHR Wellcome King's Clinical Research Facility at 17 Jun 2021

Latest COVID-19 Vaccine Study in the UK Launches in London

On Wednesday 14th April, the latest COVID-19 vaccine study was launched in London, with the King's Clinical Research Facility being one of the sites taking part. Sponsored by Canadian biopharmaceutical company Medicago and GlaxoSmithKline, the Phase 3 clinical trial will test the safety and efficacy of a plant-derived vaccine candidate named CoVLP.

By NIHR Wellcome King's Clinical Research Facility at 14 Apr 2021

Novavax confirms vaccine provides 100% protection against severe COVID-19

Final analysis of UK Phase 3 trials of Novavax's COVID-19 vaccine reveals it provides 100% protection against severe COVID-19.

By NIHR Wellcome King's Clinical Research Facility at 16 Mar 2021

Londoner proud to play his part in COVID-19 fightback by taking part in vaccine trial

A 30-year-old man has spoken about his pride in aiding the national fightback against COVID-19 by taking part in vaccine research in south London.

By NIHR Wellcome King's Clinical Research Facility at 26 Feb 2021

Novavax trial reveals 89.3% effectiveness in preventing COVID-19

Interim analysis of study shows that the NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, including effectiveness against the new variants of concern.

By NIHR Wellcome King's Clinical Research Facility at 29 Jan 2021